This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Diagnostics Operations, Inc.. Active years: 2009-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,026 
1 out of 1,698 
Years Active: 2009-2017
Title: **Innovations of Wolfgang Hoesel: A Pioneer in Antibody Research**
Introduction
Wolfgang Hoesel, based in Tutzing, Germany, is an accomplished inventor recognized for his contributions to the field of antibody research. With a total of three patents to his name, he has made significant strides in developing novel solutions that have the potential to impact medical diagnostics and treatment.
Latest Patents
One of his latest patents, titled "Anti-idiotype antibody against an antibody against the amyloid β peptide," focuses on an anti-idiotype antibody that binds to the complementary determining region of an antibody against the amyloid β peptide. This innovative approach aims to create effective immunoassays for the determination of antibodies related to the amyloid β peptide and their corresponding anti-idiotype antibodies. By targeting the same epitope or an overlapping epitope as the antibody obtainable from the cell line DSM ACC2939, his invention opens new avenues for understanding and addressing diseases linked to amyloid pathology.
Career Highlights
Throughout his career, Wolfgang has worked for several prestigious organizations, including Hoffmann-La Roche Inc. and Roche Diagnostics Operations, Inc. His involvement in these companies has helped advance his research, allowing him to develop and patent groundbreaking innovations in antibody technology.
Collaborations
Wolfgang Hoesel has collaborated with industry professionals such as Ulrich Essig and Kay-Gunnar Stubenrauch. These partnerships have fostered a productive exchange of ideas and have contributed to the successful development of his patented technologies.
Conclusion
In summary, Wolfgang Hoesel's contributions to the field of antibody research place him among notable inventors whose innovations hold promise for the future of medical science. His works, particularly in the realm of amyloid β peptides, underscore the impact of collaborative efforts within research institutions and companies dedicated to making significant advances in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile